nuclivision
Nuclivision is a science-driven AI startup based in Ghent, Belgium, focused on revolutionizing nuclear medicine. Their flagship product, Nuclarity, enhances PET scan quality using advanced AI algorithms, enabling lower radiation doses and shorter acquisition times. This improves patient safety, comfort, and access to timely diagnosis and treatment. Nuclarity integrates seamlessly with existing PACS/VNA systems and supports major scanner types and radiotracers. The company aims to reduce costs and logistical barriers in nuclear imaging, fostering a more sustainable and accessible healthcare system. Nuclivision is actively growing its team and is backed by several investment firms.
nuclivision
Nuclivision is a science-driven AI startup based in Ghent, Belgium, focused on revolutionizing nuclear medicine. Their flagship product, Nuclarity, enhances PET scan quality using advanced AI algorithms, enabling lower radiation doses and shorter acquisition times. This improves patient safety, comfort, and access to timely diagnosis and treatment. Nuclarity integrates seamlessly with existing PACS/VNA systems and supports major scanner types and radiotracers. The company aims to reduce costs and logistical barriers in nuclear imaging, fostering a more sustainable and accessible healthcare system. Nuclivision is actively growing its team and is backed by several investment firms.
TL;DR
Headquarters: Ghent, Belgium
Founded: 2022
Flagship product: Nuclarity (AI software to enhance PET image quality)
Regulatory status: CE class IIa for Nuclarity; ISO 13485
Recent funding: €5.0M seed (April 2025)
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Nuclear medicine imaging (PET) — image quality, radiation dose reduction, scan time reduction, and accessibility of diagnostic imaging.
Founded
2022
Industry
Medical Equipment Manufacturing
Tech Stack
Funding Track Record
€5,000,000
Participation from imec.istart Future Fund
Investor Signal
“Backed by specialist investors including LUMO Labs, HERAN Partners, and imec.istart Future Fund”